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Ethnicity, deprivation and screening: survival
from breast cancer among screening-eligible
women in the West Midlands diagnosed from
1989 to 2011
M Morris*,1, L M Woods1,3, N Rogers2, E O’Sullivan 2, O Kearins2 and B Rachet1,3
1Cancer Research UK Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology
and Population Health, London School of Hygiene & Tropical Medicine, Keppel St, London WC1E 7HT, UK and 2West Midlands
Breast Screening Quality Assurance Reference Centre, Public Health England, 5 St Philip’s Place, Birmingham B3 2PW, UK
Background: Social inequalities in breast cancer survival are smaller when the cancer is screen-detected. We examined survival
from screen-detected and non screen-detected breast cancer by ethnicity and deprivation.
Methods: Cancer registry data for 20 283 women aged 50–70 years, diagnosed between 1989–2011 and invited for screening,
were linked with screening and ethnicity data. We examined Asian, Black and White groups, less deprived and middle/more
deprived women. Net survival was estimated using ethnic- and deprivation-specific life tables. Estimates were corrected for lead-
time bias and over-diagnosis.
Results: Net survival varied by screening history. No significant differences in survival were found by ethnicity. Five-year net
survival was 90.0% (95% CI, 89.3–90.8%) in less deprived groups and 86.7% (85.9–87.4%) among middle/more deprived women.
Screening benefitted all ethnic and both deprivation groups. Whether screen-detected or not, more deprived women had
significantly poorer outcomes: 5-year net survival was 78.0% (76.7–79.2%) for deprived women who were not screen-detected
compared with 94.0% (93.1–95.1%) for less deprived women who were screen-detected.
Conclusions: The three ethnic groups differed little in their breast cancer survival. Although screening confers a survival benefit to
all, there are still wide disparities in survival by deprivation. More needs to be done to determine what underlies these differences
and tackle them.
There is evidence that there are substantial socio-economic (Rachet
et al, 2010) and ethnic (dos Santos Silva et al, 2003; Farooq and
Coleman, 2005; Jack et al, 2009) differences in breast cancer survival:
survival is higher in more affluent women, and in those from White
and South Asian ethnic groups, and lower among women from
more deprived areas and among Black African women.
Possible explanations for these inequalities include later
presentation leading to later stage of disease (Sant et al, 2003;
Woods et al, 2006; Jack et al, 2009), and differences in screening
uptake by both socio-economic status (Maheswaran et al, 2006;
Gatrell et al, 1998) and ethnicity (Szczepura et al, 2008; Price et al,
2010; Renshaw et al, 2010).
Analyses of cancer registry data linked to the National Breast
Screening Service records also showed smaller socio-economic and
ethnic differences for screen-detected cancer (NHS Cancer Screening
Programmes, 2009). However, the overall difference in breast cancer
*Correspondence: Dr M Morris; E-mail: melanie.morris@lshtm.ac.uk
3These authors contributed equally to this work.
Received 4 February 2015; revised 29 April 2015; accepted 12 May 2015;
published online 16 June 2015
& 2015 Cancer Research UK. All rights reserved 0007 – 0920/15
FULL PAPER
Keywords: ethnic groups; socio-economic factors; breast neoplasms; survival analysis; mass screening; mammography; Great
Britain
British Journal of Cancer (2015) 113, 548–555 | doi: 10.1038/bjc.2015.204
548 www.bjcancer.com |DOI:10.1038/bjc.2015.204
survival between affluent and deprived women was not modified by
the introduction of screening in 1989 (Coleman et al, 2004).
As ethnic minority women are more likely to be diagnosed with
breast cancer at younger ages than White women (NHS Cancer
Screening Programmes, 2009; Jack et al, 2012), screening has had
less potential to reduce the overall ethnic disparities in survival
while offered to those over 50. However, as women are invited
for screening at a younger age of 47 years, this may change
(NHS Cancer Screening Programmes, 2009). Breast cancer
incidence also appears to be increasing among ethnic minorities
despite historically being lower than that among White groups
(Farooq and Coleman, 2005; Jack et al, 2009; Stotter et al, 2014),
which makes this issue even more important.
In this descriptive study, we have used data from a centre of
excellence in breast cancer registration (the West Midlands Cancer
Registry) to map out the current picture of breast cancer survival
among different socio-demographic groups. Our aim was to describe
survival differences between ethnic and deprivation groups, and
whether screening status has an impact on these. To this end we
quantify survival by deprivation, ethnicity and mode of presentation.
MATERIALS AND METHODS
Sources of data. The West Midlands Breast Screening Quality
Assurance Reference Centre (QARC) has assigned a screening
status to every confirmed primary malignant (invasive and in situ)
breast cancer diagnosed in the region since the start of screening in
1989 (Lawrence et al, 2005). This resource is the largest and most
complete of its kind in England (UK Association of Cancer
Registries, 2010). These data are also linked to the Hospital Episode
Statistics (HES) and National Breast Screening Service (NBSS)
records, and are regularly linked to the National Mortality
Database for updates of vital status. Follow-up was complete up
to the end of July 2012 for all women.
Cohort selection. The cohort was defined as women diagnosed
with a primary, invasive breast cancer during the period 1 April
1989–31 March 2011 and aged 50–70 years at their diagnosis. It
consisted of women who were continuously eligible for screening
from the age of 50 up to either 65 or 70 years (if the screening
service expanded), who would have received their first invitation
letter from their 50th birthday onwards and who would have kept
receiving invitation letters until they were a maximum of 70 years
old (Figure 1A). Figure 1B shows the accumulation of the cohort
over the course of the study period, up to a total of 20 283 women,
after excluding 761 women (3.6% of those eligible). These
exclusions mainly comprised women whose tumours were
recurrences of earlier malignancies.
Ethnicity data
Sources. Data on each woman’s ethnicity was gathered from self-
reports given on admittance to hospital (from HES data), or in
some cases, on presentation for breast screening (from NBSS data).
HES records provided ethnicity information for 16 747 women
who had, at some point, had an inpatient stay and reported their
ethnicity (83% of the cohort). The NBSS provided data for a
further 1425 women (7%) where HES data were missing. Among
the 6258 observations with information from both sources, the
proportion of agreement was 98.6% (Kappa¼ 0.80, Po0.001)
indicating that the NBSS was a robust source for the missing data.
We imputed the remaining 10% of ethnicity data using name-
recognition software, Onomap (Lakha et al, 2011; Supplementary
Table A). This software uses the first and last names of people in
the sample to match to databases of names from different
ethnicities, and so can be used to impute ethnicity where no other
information exists.
Categorisation. Some women had several HES records due to
repeated inpatient stays, and some had multiple ethnicities
reported. A hierarchy was applied in order to derive a single code
for these women as follows: (i) the most common code was used,
(ii) the most recent code was used, if there was an equal number of
one code and (iii) alphanumerically, if there was an equal number
of one code on same date (B0.001% patients). Three main ethnic
categories were created: Asian (all groups including from mixed
heritage), Black (all groups including from mixed heritage) and
White (including mixed heritage other than Black/Asian and
‘other’; Supplementary Table A).
Assigning deprivation score. Two different ecological measures of
deprivation were used according to the study period: an updated
Townsend score (Townsend et al, 1988) for women diagnosed with
a breast cancer between 1990 and 2000 (40% of cases); the 2004,
2007 and 2010 scores of the Income Domain of the Index of
Multiple Deprivation (IMD; 21.4%, 26.5% and 12.2%, respectively)
for women diagnosed from 2001 onwards. The women were
assigned a score according to their geographical area of residence at
the time of their diagnosis (Department of the Environment
Transport and the Regions, 2000; Neighbourhood Renewal Unit,
2004). The IMD scores used Lower Super Output Areas (B1500
people), whereas electoral wards had been used previously (average
population of 5500 people). The scores were split into five categories
based on the quintiles of the national distribution of the areas.
Screening history. Breast cancer diagnoses in the cancer registry
are linked to the woman’s screening history by the QARC.
Women were categorised according to how their cancer was
diagnosed and their screening history: (i) women with
screen-detected cancer (no matter how many previous screens
she may have had), (ii) women whose last screening attendance
had resulted in a negative screen and had not yet been invited
to a subsequent screening (interval cancer), (iii) those whose
cancer was diagnosed after having previously had a negative
screen, but who had not attended their most recent screening
appointment (lapsed attenders), (iv) women who had
never presented for screening (non-attenders). The last three
categories encompass women whose cancer has been detected
symptomatically and were grouped for the main analyses as not
screen-detected.
Stage of disease. The West Midlands Cancer Registry provided
information on tumour size, node involvement and presence of
metastases. This information was converted into a variable for
‘extent of disease’ (localised¼ confined to the organ of origin,
regional¼ spread to adjacent muscle, organ, fat, connective tissue
or regional lymph nodes, and distant¼ distant metastases).
Analysis. We estimated net survival using the non-parametric
Pohar Perme estimator (Pohar Perme et al, 2012) implemented in
stns: software available for Stata 13 (StataCorp, 2013). Net survival
provides an estimate of survival from the cancer itself, adjusting for
expected mortality from other causes. The Pohar Perme estimator
has been shown to provide unbiased estimates of net survival from
population-based data (Danieli et al, 2012; Roche et al, 2013).
We estimated the expected survival from ethnic life tables for
England and Wales. We have constructed ethnic-majority life
tables for 2001 (Morris et al, 2015) making use of census data
about the ethnic make-up of very small geographical areas, and
mortality data provided by the Office for National Statistics. We
interpolated life tables up to 2012 on the bases of these 2001
ethnic-specific tables and the England and Wales life tables for
each of the 2002–2012 years.
To account for the potential effect of lead-time bias in the
screen-detected group, we applied the method established by Duffy
et al (2008). For each patient, additional survival time due
to screening, E(s), was estimated, assuming an exponential
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distribution of survival times and mean sojourn time of 4 years
(Duffy et al, 2008). In order to account for the uncertainty
associated with this value, we then generated ten separate data sets
for the screen-detected group containing E(s)1, E(s)2 y E(s)10
assuming these values were exponentially distributed with a mean
of E(s). This resulted in a range of estimates for the possible
additional survival due to lead time which were then subtracted
from observed survival time in order to obtain corrected survival
time.
We considered tumours to be over-diagnosed if they would not
have been detected symptomatically during the study period or
during the woman’s predicted life time. We therefore excluded
tumours in instances where the value of E(s) exceeded the woman’s
actual observed survival time, either because the predicted date of
diagnosis was after 31 March 2011, or in excess of her life
expectation at diagnosis.
We used the corrected survival times to estimate non-
parametric net survival for each data set of the screen-detected
group. We applied the rules established by Rubin (1987) for the
re-combination of estimates in a multiple-imputation setting to
derive an overall estimate of net survival and its variance, adjusted
for lead-time bias and over-diagnosis.
We applied locally weighted regression to smooth the survival
estimates (Cleveland, 1979; Royston, 1991), using a conservative
degree of smoothing to maintain the variability evident in the more
sparse data. When corrected estimates were used (in comparisons
involving screen-detected women), however, smoothing was not
applied as there were too few data points in some of the groups for
the patterns to be evident.
RESULTS
Cohort characteristics. The distribution of women by deprivation
varied substantially by ethnicity. White women were more likely to
be affluent than either Asian or Black women (Table 1). The mean
age of women in the cohort was 57.5 years (s.d.¼ 5.0 years). The
White group of women were somewhat older.
The proportion of women diagnosed with localised disease was
60.3% in the White group, but much lower among Asian women
(55.8%) and particularly among Black women (46.6%). Black
women had a commensurately higher proportion of regional
disease (45.5% compared with 35.8% in Asian women and 31.1%
in White women, Po0.001).
Half of the White (51.9%) and Asian (50.0%) women in the
study had screen-detected breast cancer, but among Black women
the proportion was lower (45.0%, Po0.001) (Table 2). Although
Asian women had the smallest proportion of interval cancers
(24.2%), they were the most likely to be lapsed or non-attenders
(Po0.001). Screening status also varied by deprivation: there was
little difference in the proportions that were screen-detected across
the deprivation categories, but there was a clear increase in the
proportion who were lapsed or non-attenders from the least to the
most deprived (Po0.001).
Survival analysis
Survival by ethnicity. Figure 2A shows net survival from breast
cancer for each ethnic group. Women in the Black groups show
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Figure 1. (A) Cohort selection diagram and (B) accumulation of the cohort through the study period, women diagnosed between 1 April 1989–
31 March 2011, followed up to 31 July 2012.
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consistently lower survival than the other groups, but there are no
significant differences found, because the confidence intervals are
wide for the minority groups and they overlap fully at every time
point.
All ethnic groups had high survival when the disease was
localised at diagnosis. Survival was much lower among those with
regional and distant disease. There was very little survival
difference between the ethnic groups, except some slight suggestion
that Black women fared worse for long-term survival than other
groups when their disease was localised (Figure 2B).
Survival has improved in each time period overall and for Asian
and White ethnic groups, but no significant gains could be seen in
Black groups (Supplementary Figure A). However, there were too
few data points in the earliest time period in the Asian and Black
groups to show after smoothing.
Survival by deprivation. There was a significant survival differ-
ence between the less deprived and the middle and more deprived
groups (Figure 3A) at every follow-up time. Five-year survival, for
example, was 90.0% (95% CI, 89.3–90.8%) in less deprived groups
and 86.7% (85.9–87.4%) in the middle and more deprived groups,
with gaps widening with time.
Survival was similar for each ethnicity when split by deprivation,
however (Figure 3B). Survival for the middle and more deprived
Black women seemed to be lower than in similarly deprived
women in the other two ethnic groups. There were very few Black
women in the higher socio-economic categories, which made a
robust comparison difficult.
There was a significant survival difference for White women
between the less deprived vs the middle and more deprived groups,
similar to that seen in the overall graph (Figure 3A). Small
numbers in the two minority ethnic groups prohibited a valid
comparison by deprivation (data not shown).
Survival by screening status. In all ethnic and deprivation groups,
those with screen-detected cancer had the best 5-year survival,
whereas non-attenders had the poorest, after those diagnosed with
interval cancers and lapsed attenders (Table 2).
The graphs below use estimates for screen-detected women
corrected for lead-time bias and potential over-diagnosis so that
their results can be compared, without bias, with those of non
screen-detected women.
There was a clear benefit in all ethnic groups for those who have
been screen-detected vs those who have not (Figure 4A) and there
were no evident ethnic differences within screening categories.
Survival was more similar for the screen-detected group, whilst
Black women appeared to have consistently lower survival in the
non screen-detected group. However, these differences were not
statistically significant.
In contrast, clear differences were found between deprivation
groups within each category of screen detection. Screen detection
again conferred a clear benefit in both deprivation groups but,
whether screen-detected or not, women in the middle and more
deprived categories had significantly poorer survival (Figure 4B). At 5
years, there was a difference of 16% between the net survival of
highest surviving group (less deprived women who were screen-
detected, 94.0%; 95% CI, 93.1–95.1%) and the lowest surviving group
(the middle and more deprived women who were not screen-detected,
78.0%; 95% CI, 76.7–79.2%). The gap was even wider at 10 years.
DISCUSSION
This study describes the survival from breast cancer of a cohort of
women from the West Midlands, by their ethnicity, period of
diagnosis, extent of disease at diagnosis, deprivation status and
screening history. After correcting for background mortality for
Table 1. Cohort characteristics by ethnicity
n¼20283 Asian, n (%) Black, n (%) White, n (%) Total, n (%) P-value (v2)a
Age group at diagnosis (years)
50–54 230 (39.0) 76 (39.8) 6575 (33.7) 6881 (33.9) 0.006
55–59 189 (32.0) 60 (31.4) 6096 (31.3) 6345 (31.3)
60–64 128 (21.7) 34 (17.8) 4703 (24.1) 4865 (24.0)
65–70 43 (7.3) 21 (11.0) 2128 (10.9) 2192 (10.8)
Period of diagnosis
1989–1994 21 (3.6) 8 (4.2) 772 (4.0) 801 (3.9) 0.077
1995–2000 92 (15.6) 30 (15.7) 3719 (19.1) 3841 (18.9)
2001–2006 214 (36.3) 76 (39.8) 7502 (38.5) 7792 (38.4)
2007–2011 263 (44.6) 77 (40.3) 7509 (38.5) 7849 (38.7)
Vital status at the end of follow up
Dead 103 (17.5) 43 (22.5) 3586 (18.4) 3732 (18.4) 0.286
Deprivation quintile
Least deprived 48 (8.1) 10 (5.2) 4420 (22.7) 4478 (22.1) o0.001
2 52 (8.8) 20 (10.5) 4542 (23.3) 4614 (22.7)
3 86 (14.6) 25 (13.1) 4065 (20.8) 4176 (20.6)
4 113 (19.2) 33 (17.3) 3400 (17.4) 3546 (17.5)
Most deprived 291 (49.3) 103 (53.9) 3057 (15.7) 3451 (17)
Missing 0 (0) 0 (0) 18 (0.1) 18 (0.1)
Deprivation group
Less deprived (quintiles 1þ 2) 100 (16.9) 30 (15.7) 8962 (46.0) 9092 (44.8) o0.001
Middle and more deprived (quintiles 3þ4þ5) 490 (83.1) 161 (84.3) 10 522 (54.0) 11 173 (55.1)
Missing 0 (0) 0 (0) 18 (0.1) 18 (0.1)
Extent of disease
Localised 329 (55.8) 89 (46.6) 11 758 (60.3) 12 176 (60.0) o0.001
Regional 211 (35.8) 87 (45.5) 6066 (31.1) 6364 (31.4)
Distant 18 (3.1) 3 (1.6) 462 (2.4) 483 (2.4)
Missing 32 (5.4) 12 (6.3) 1216 (6.2) 1260 (6.2)
Total 590 (100.0) 191 (100.0) 19 502 (100.0) 20 283 (100.0)
aw2 test performed on non-missing data only.
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each group, survival from breast cancer was not found to vary
significantly by ethnic group in this sample. There was also little
difference between ethnicities when examining survival by extent
of disease or by deprivation. However, a deprivation gap was
apparent overall. We found clear evidence of a survival benefit of
screening for women in all ethnic groups, and in different
deprivation groups. However, large differences were also found
within screening categories for the deprivation groups, with those
less deprived showing a clear benefit whether screen-detected or not.
Women who were diagnosed in the earliest time
periods had lower survival. However, excluding these women did
not impact the inequalities seen by deprivation. In the most recent
time periods, there is little evidence of a deprivation gap up
to 5 years after diagnosis (data not shown), but given that the
deprivation gap widens beyond 5-year survival in earlier
time periods, it remains to be seen whether the discrepancy will
still be evident with longer follow-up in those diagnosed more
recently.
Table 2. Net survival for women with different screening histories, by ethnicity and deprivation
Total Screen-detected Interval Lapsed attender Non-attenderþothera
Total 20283 (100) 10509 (51.8) 6313 (31.1) 1143 (5.6) 2318 (11.4)
Ethnicityb
Asian n (%) 590 (100) 295 (50.0) 143 (24.2) 48 (8.1) 104 (17.6)
Net survival 1 year 98.5% (96.6–100.3%) 97.5% (94.8–100.2%) 92.1% (84.3–99.8%) 93.5% (88.7–98.4%)
5 years 91.3% (86.7–96.2%) 83.8% (76.8–90.8%) 82.3% (70.4–94.2%) 75.5% (66.3–84.7%)
Black n (%) 191 (100) 86 (45.0) 66 (34.6) 11 (5.8) 28 (14.7)
Net survival 1 year — 98.7% (95.8–101.6%) 91.0% (74.8–107.2%) 89.8% (78.4–101.1%)
5 years 92.0% (91.2–92.8%) 79.2% (68.0–90.37%) — 71.8% (53.8–89.8%)
White n (%) 19 502 (100) 10 128 (51.9) 6104 (31.3) 1084 (5.6) 2186 (11.2)
Net survival 1 year 98.4% (98.1–98.7%) 97.6% (97.2–98.0%) 95.4% (94.1–96.7%) 88.9% (87.6–90.3%)
5 years 91.2% (82.4–101.0%) 84.3% (83.3–85.4%) 78.9% (76.0–81.9%) 68.9% (66.7–71.0%)
Deprivation quintileb
Least deprived 4478 (100) 2320 (51.8) 1562 (34.9) 217 (4.8) 379 (8.5)
Net survival 1 year 98.9% (98.3–99.4%) 98.1% (97.3–98.9%) 96.7% (94.2–99.2%) 90.1% (87.0–93.1%)
5 years 93.9% (92.5–95.4%) 86.1% (84.1–88.1%) 81.2% (75.0–87.3%) 73.0% (68.1–77.9%)
2 4614 (100) 2380 (51.6) 1534 (33.2) 251 (5.4) 449 (9.7)
Net survival 1 year 98.8% (98.2–99.4%) 98.1% (97.4–98.9%) 95.0% (92.1–97.8%) 90.8% (88.1–93.5%)
5 years 93.7% (92.2–95.3%) 84.4% (82.3–86.5%) 81.41 (75.7–87.1%) 74.3% (69.9–78.8%)
3 4176 (100) 2232 (53.4) 1296 (31.0) 219 (5.2) 429 (10.3)
Net survival 1 year 98.5% (97.8–99.2%) 97.7% (96.8–98.6%) 94.6% (91.5–97.8%) 89.4% (86.5–92.4%)
5 years 91.9% (90.2–93.7%) 84.7% (82.4–87.0%) 80.91% (74.6–87.2%) 69.3% (64.5–74.2%)
4 3546 (100) 1830 (51.6) 1032 (29.1) 193 (5.4) 491 (13.8)
Net survival 1 year 98.1% (97.4–98.9%) 97.4% (96.3–98.4%) 94.8% (91.6–98.1%) 87.9% (85.0–90.9%)
5 years 89.8% (87.7–91.9%) 81.5% (78.7–84.2%) 74.45 (66.9–82.0%) 69.0% (64.5–73.4%)
Most deprived 3451 (100) 1740 (50.4) 887 (25.7) 262 (7.6) 562 (16.3)
Net survival 1 year 97.6% (96.7–98.5%) 96.7% (94.2–99.2%) 94.8% (92.0–97.7%) 87.9% (85.2–90.7%)
5 years 89.0% (86.8–91.1%) 81.2% (75.0–87.3%) 76.71 (70.5–83.0%) 62.3% (57.9–66.8%)
Missing data 18 (100) 7 (38.9) 2 (11.1) 1 (5.6) 8 (44.4)
Note: Confidence intervals over 100% indicate that the survival of the group is not significantly different from the background mortality found in the life tables.
aCeased/not known/irresolvable n¼ 276 (1.4%).
bw2 test comparing proportion of each ethnic group by screening history Po0.001; comparing each deprivation group by screening history Po0.001.
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Figure 2. Net survival (A) by ethnicity, showing 95% confidence intervals (CIs), and (B) by ethnicity and extent of disease, corrected for
background mortality using ethnic life tables adjusted for deprivation. Note that for clarity, CIs are not shown on graphs from now on where they
fully overlap; too few data points in the Black group for distant disease (graph B) to show after smoothing.
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We have been able to compare patterns of survival from breast
cancer between the three main ethnic groups among screening age
women for the first time. Because of small numbers in minority
groups, we used broad groupings of ethnicity. We also added
women self-identified as ‘mixed ethnicity’ into the minority group
that they identified as part of their mixed background. This
decision was based on the fact that the ‘mixed’ category is
heterogeneous partly because of the different minorities repre-
sented (Bradford, 2006; Platt, 2011). However, there is little
literature confirming that these women are more likely to be more
similar to their minority background than to White groups in their
health behaviours.
We will have missed some of the diversity in health outcomes
still to be found within these broad ethnic groups (Atkin et al,
2010). These broad categories tell us little regarding the cultural or
faith differences within them. These might themselves have a large
impact on healthcare-seeking behaviour, lifestyle choices and
support structures (Acheson, 1998; Renshaw et al, 2010).
Expanding this study to cover the whole of UK would allow us
to examine some more fine-grained differences.
Despite being limited to the West Midlands area, the data came
from a centre of excellence for breast cancer registration. They
contained only women who would have been invited for screening,
and were linked with several data sources to achieve highly
complete self-reported ethnic identity, augmented by imputation
from names for only 10% of the cohort. The completeness of self-
reported ethnicity information is much higher than in many
studies which have attempted to quantify the effect of ethnicity on
breast cancer survival: completeness was generally around two
thirds (NHS Cancer Screening Programmes, 2009; Jack et al, 2009;
2012) or three quarters (National Cancer Intelligence Network and
Cancer Research UK, 2009). Despite recent improvements, the
Second All Breast Cancer Report still achieved lower completeness
(80%) in their 2007 data for England, and Davies et al (2013)
achieved 77% in London.
This method of linking different sources of ethnicity data has been
used successfully elsewhere, and is advocated for improving ethnicity
data (Aspinall and Jacobson, 2007). Onomap sensitivity is high for
White and Asian names (99.8% and 82.1%, respectively), but very low
for Black names (4.4%; Ryan et al, 2012). We compared Onomap-
assigned ethnicity in our sample with self-reported ethnicity for those
women with both sources of ethnicity information. This gave a
sensitivity of 99.6%, 80.8% and 3.3% for White, Asian and Black
names, respectively, and specificities of 14.9%, 99.5% and 99.9%,
respectively, which corresponds closely with that previously found.
Where women had multiple ethnicities reported, which could be
due to changing self-perception, recording errors or changes in coding
methods, the algorithm used by the West Midlands Breast Screening
QARC ensured a consistent approach for dealing with them.
Appropriate adjustments and corrections. It is essential in net
survival analysis to use life tables which account as closely as
possible for the background mortality specific to each sub-group
(Dickman et al, 1998; Blakely et al, 2012). The recent derivation of
deprivation-adjusted ethnic life tables (Morris et al, 2015) enables us
to apply the best possible correction (Supplementary Figure B).
When we compared the net survival estimates after correcting with
these life tables with those corrected only with regional, deprivation-
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specific life tables, we saw smaller changes (not shown). For
instance, breast cancer survival in Black women was slightly lower
using the regional life tables. This means that differences in survival
between ethnicities appear greater if ethnic life tables are not used.
A concern when estimating survival has been the lead-time
effect (Hutchison and Shapiro, 1968) in which survival time
appears artificially increased as tumours are diagnosed earlier by
screening than they would have been symptomatically, but without
improvement in prognosis (Ellis et al, 2014). The correction we
applied, however, enables a direct comparison between women
with screen-detected and non screen-detected cancers (Duffy et al,
2008; Lawrence et al, 2009). In addition we corrected for potential
over-diagnosis, ensuring that those women whose cancer would
not have been diagnosed symptomatically during the study period
or during the patient’s life time were excluded. We applied these
corrections in any comparison of screen-detected and non screen-
detected women to enable an unbiased comparison. Omitting these
corrections would have over-estimated long-term net survival for
screen-detected women (Supplementary Figure C).
Length bias can also exaggerate the potential survival advantage
of screen-detected women in comparison with non screen-detected
women. This is the tendency for slower growing tumours with better
overall prognosis to be more likely to be detected by mammography.
Duffy et al (2008) have shown, by means of a sensitivity analysis,
that the impact of this bias is relatively small, reducing the 10-year
survival for the screen-detected group by only 1%.
Comparison with other studies. There are some discrepancies in
results between studies. Some have found slightly higher survival
from breast cancer for South Asian women, for example, compared
with non-South Asians (dos Santos Silva et al, 2003; Farooq and
Coleman, 2005). These studies, which assigned ethnicity with a
name-based software (SANGRA (Nanchahal et al, 2001)), used
national life tables to account for the background mortality. By
contrast, the NHS All Breast Cancer reports, based on 2006 and 2007
data, found a small, non-significant, survival advantage for Asian
women but the 5-year relative survival for Black and White groups
were found to be the same as each other (NHS Cancer Screening
Programmes, 2009; National Cancer Intelligence Network, 2011).
These studies used deprivation-specific national life tables. Our study
corrected for background mortality by both deprivation and
ethnicity. These corrections are crucial because the proportion of
women in our data from more deprived categories was much higher
in the Asian and Black ethnic groups, compared with that in the
White groups. Similar proportions were found in the NHS All Breast
Cancer Reports (NHS Cancer Screening Programmes, 2009; National
Cancer Intelligence Network, 2011) for White groups, using data
from all of England using 2001 Census information.
The benefit of screening to all groups tallies with findings from
several other studies (Lawrence et al, 2009; NHS Cancer Screening
Programmes, 2009; National Cancer Intelligence Network, 2011), as
does the deprivation gap seen (NHS Cancer Screening Programmes,
2009; Rachet et al, 2010; National Cancer Intelligence Network,
2011; Davies et al, 2013). The same caveat applies as above, however,
as this study takes these results a step further by using the most up-
to-date methods of net survival analysis and, for the first time, the
ethnic- and deprivation-specific life tables.
Half of our cohort had screen-detected breast cancer which
contrasts to some other studies which found lower proportions,
especially among Black women (NHS Cancer Screening Programmes,
2009; National Cancer Intelligence Network, 2011; Davies et al, 2013),
and also in Indian women (Davies et al, 2013). This could be due to
the fact that we restricted our sample only to women who would have
been invited for screening, rather than just identifying all women
within the screening age range, as is commonly done.
The Black women in our sample were slightly less likely to have
been screen-detected than the other ethnic groups and the Asian
women were more likely than the White group to be lapsed or non-
attenders. The age range chosen for our sample might explain
some differences to other studies, as breast cancer is more likely to
occur before age 50 in Black women (NHS Cancer Screening
Programmes, 2009; National Cancer Intelligence Network, 2011).
This also explains why in this sample the White women were older
than the women in other groups. It may also be related to lower
screening uptake among more deprived socio-economic groups
(Banks et al, 2002; Maheswaran et al, 2006; NHS Cancer Screening
Programmes, 2009) as a greater proportion of Black women reside
in these areas. Some researchers contend, however, that socio-
demographic factors are not solely responsible for uptake, but that
health behaviour differences and other experiences with cancer may
be more important (Lagerlund et al, 2000; Szczepura et al, 2008).
Uptake of screening among ethnic groups is likely to have
changed over the time covered by our data. Some research, which
adjusted for deprivation and age, has found that although there may
still be ethnic differences in uptake, these may be decreasing as time
goes on (Szczepura et al, 2008). The similarity or difference in
uptake by different ethnic groups would not have directly impacted
our results as we have examined survival among those whose cancer
was screen-detected and among those whose cancer was not.
CONCLUSIONS
This study showed a heartening lack of difference between ethnic
groups in survival from breast cancer over the course of time since
screening started, although the deprivation gap was still very much
apparent despite screening attendance. By using the best analysis
methods to describe the data and correcting for potential biases, we
have produced a robust result that can now be built upon. The
overriding message is that, for all ethnic groups, attendance at screening
has a beneficial long-term effect on survival, however more work needs
to be done to tackle economic inequalities in survival. Initiatives to
inform women about breast cancer screening programmes, and so
enable them to make an informed choice regarding attendance, should
prioritise women from the more deprived communities.
Future research will explore various potential explanatory
factors through multivariable modelling, including the timing of
treatments received and of tumour biology, as these could go some
way to explain the survival differences found between deprivation
groups. Larger studies that use UK-wide data would be able to
investigate patterns hidden within these broader ethnic groups.
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